Correction: Comparison of in vitro and in vivo toxicity of bupivacaine in musculoskeletal applications - Takeaways - MDSpire

Correction: Comparison of in vitro and in vivo toxicity of bupivacaine in musculoskeletal applications

  • By

  • Jasper G. Steverink

  • Susanna Piluso

  • Jos Malda

  • Jorrit-Jan Verlaan

  • May 26, 2026

  • 0 min

Share

  • 1

    A correction was issued for the article evaluating bupivacaine's toxicity in musculoskeletal contexts.

  • 2

    An error in figure 2 was identified, leading to its removal from the published article.

  • 3

    The incorrect figure contained an unexpected image overlap, as flagged on PubPeer.

  • 4

    The figure caption was updated to accurately reflect light microscopy images of LA-induced myotoxicity.

  • 5

    The original article has been revised to correct these inaccuracies and ensure clarity.

Original Source(s)

Correction: Comparison of in vitro and in vivo toxicity of bupivacaine in musculoskeletal applications

  • by Jasper G. Steverink, Susanna Piluso, Jos Malda, Jorrit-Jan Verlaan

  • May 26, 2026

Related Content

Therapeutic scarification, shadow pain, and integrative geriatric rehabilitation for chronic musculoskeletal pain in older adults in Cameroon: a prospective mixed-methods observational study

Meniscal repair and partial meniscectomy demonstrated similar clinical outcomes with simultaneous combined anterior cruciate ligament and anterolateral structure reconstruction

Correction: Quality of life reported by patients with ecchymosis following total knee arthroplasty